Results 211 to 220 of about 6,119,378 (259)

Analysis of remobilization efficiency of etoposide combined with cytarabine and pegfilgrastim, with or without plerixafor, for multiple myeloma recurrence following autologous hematopoietic stem cell transplantation. [PDF]

Clin Exp Med
Zhou Y, Qian H, Zheng J, Lu Y, Ye P.
europepmc   +1 more source

The effectiveness and reliability of autologous hematopoietic stem cell transplantation following chemotherapy in managing malignant lymphoma: a meta-analysis. [PDF]

Discov Oncol
Ahmed H, Shafiey AS, Abdelrahim MEA.
europepmc   +1 more source

Late Relapse After Autologous Hematopoietic Stem Cell Transplantation in AQP4-IgG-Positive NMOSD.

JAMA Netw Open
Vorasoot N, Blackburn KM, Nguyen L, Bush ML, Jenkins SM, Jitprapaikulsan J, Fryer JP, Irani SR, Flanagan EP, Pittock SJ.   +9 more
europepmc   +1 more source

[The correlation between lymphocyte subsets before autologous hematopoietic stem cell transplantation and hematopoietic reconstruction and recurrence after transplantation in multiple myeloma]. [PDF]

Zhonghua Xue Ye Xue Za Zhi
Zhang LL, An FR, Xie BB, Wang YS, Hou JX, Qin H, Dong Y, Zhai ZM, Tao LL.   +8 more
europepmc   +1 more source

Longitudinal immune profiling following autologous hematopoietic stem cell transplantation in multiple sclerosis: insights into immune reconstitution and disease modulation. [PDF]

Front Immunol
Müller M, Pavlovic I, Wiberg A, Burman J.   +3 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Complications of autologous hematopoietic stem cell transplantation

Haematologia, 2000
Myeloablative therapy followed by autologous hematopoietic stem cell (HSC) transplantation is a therapeutic option proposed for a variety of hematological and non-hematological diseases. However, although mortality due to this procedure is steadily decreasing, patients are still exposed to the risk of a number of complications negatively affecting ...
G, Lambertenghi Deliliers, C, Annaloro, D, Lambertenghi Deliliers   +2 more
openaire   +2 more sources

Autologous Hematopoietic Stem-Cell Transplantation for Multiple Myeloma

New England Journal of Medicine, 2009
A 59-year-old man is diagnosed with multiple myeloma. It is recommended that he receive induction therapy followed by high-dose melphalan with autologous hematopoietic stem-cell transplantation. Such transplantation improves the remission rate in myeloma by allowing for the administration of a chemotherapy dose that would otherwise be lethal.
Jean-Luc, Harousseau, Philippe, Moreau
openaire   +2 more sources

Mobilization of Hematopoietic Stem Cells for Use in Autologous Transplantation

Clinical Journal of Oncology Nursing, 2010
Autologous hematopoietic stem cell transplantation (HSCT) is a potentially curative therapeutic approach for various malignant hematologic and lymphoid diseases. Hematopoietic stem cells (HSCs) may be collected from the blood or the bone marrow. HSCs are capable of self-renewal and give rise to progenitor cells, multipotent cells that differentiate and
Hollie, Devine, D Kathryn, Tierney, Kim, Schmit-Pokorny, Kathleen, McDermott   +3 more
openaire   +2 more sources

Application of autologous hematopoietic stem cell transplantation for pemphigus

International Journal of Dermatology, 2017
AbstractBackgroundPemphigus is a rare and fatal autoimmune disease for which the treatment options are limited. This study aimed to evaluate the efficacy of autologous peripheral hematopoietic stem cell transplantation (APHSCT) for pemphigus.MethodsWe conducted APHSCT for 12 pemphigus patients (seven males and five females, mean age 23.8 years) with ...
Menglei, Wang, Can, Cao, Jing, Sun, Xuebiao, Peng, Qifa, Liu, Liang, Huang, Yanyan, Chai, Kuan, Lai, Pingjiao, Chen, Qingxiu, Liu, Qian, Li, Yusheng, Peng, Hao, Xiong, Jing, Zhang, Minghua, Chen, Kang, Zeng   +15 more
openaire   +2 more sources